| # | Drug | Count |
|---|---|---|
| 0 | INSULIN LISPRO | 57 |
| 1 | INSULIN GLARGINE | 52 |
| 2 | INSULIN | 39 |
| 3 | INSULIN HUMAN | 32 |
| 4 | BEVACIZUMAB | 29 |
| 5 | RANIBIZUMAB | 29 |
| 6 | INSULIN ASPART | 28 |
| 7 | METFORMIN | 16 |
| 8 | METFORMIN ER 500 MG | 11 |
| 9 | METFORMIN ER 750 MG | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN ASPART INJECTION | 7 | 0.0026 |
| 1 | ODEVIXIBAT | 1 | 0.0025 |
| 2 | METRELEPTIN | 2 | 0.0016 |
| 3 | DEXTROMETHORPHAN POLISTIREX | 1 | 0.0013 |
| 4 | RANIBIZUMAB | 29 | 0.0011 |
| 5 | INSULIN HUMAN | 32 | 0.0008 |
| 6 | HUMAN INSULIN | 5 | 0.0007 |
| 7 | ECALLANTIDE | 1 | 0.0005 |
| 8 | OSILODROSTAT | 1 | 0.0005 |
| 9 | INSULIN ASPART | 28 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 140 |
| 1 | Insulin [EPC] | 37 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 29 |
| 3 | Corticosteroid [EPC] | 17 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 11 |
| 5 | GLP-1 Receptor Agonist [EPC] | 11 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 11 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 10 |
| 8 | Loop Diuretic [EPC] | 10 |
| 9 | Atypical Antipsychotic [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 1 | Leptin Analog [EPC] | 2 | 0.0016 |
| 2 | Insulin [EPC] | 37 | 0.0008 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 5 | Insulin Analog [EPC] | 140 | 0.0003 |
| 6 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 7 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 8 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |